Ovarian Tumor Cells
Ovarian cancer remains the deadliest gynecologic malignancy, largely due to late diagnosis and the development of therapy resistance. Our collection of ovarian tumor cell lines provides essential tools for studying the complex biology of epithelial ovarian cancers (EOCs) and other ovarian tumor types.
This portfolio offers a range of well-characterized, reliable in vitro models to investigate tumorigenesis, metastasis, drug response, and mechanisms of resistance, particularly to platinum-based chemotherapies.
Relevant Authenticated Diverse Supported
Key Features & Expertise
Our ovarian tumor cell lines are designed to address critical research needs
Clinically Relevant Model Diversity
- Covers major histologic subtypes: high-grade serous, endometrioid, clear cell, and mucinous carcinomas
- Includes models with different BRCA1/2 statuses and homologous recombination proficiency/deficiency (HRD)
- Features both primary tumor-derived and metastatic ascites-derived cell lines
Comprehensive Molecular & Functional Profiling
- Genomic data on key drivers (TP53, BRCA1/2, KRAS, PIK3CA) and copy number variations
- Documented responses to standard-of-care agents (carboplatin, paclitaxel, PARP inhibitors)
- Characterized for features like spheroid formation and invasive potential, suitable for 2D and 3D assays
Quality-Certified & Supported
- Each cell line is STR-profiled for unambiguous identity verification
- Rigorously tested and certified mycoplasma-free for experimental integrity
- Supported with detailed culture protocols and batch-to-batch consistency
FAQ
Which ovarian tumor cell line is best for studying platinum resistance?
For modeling acquired platinum resistance, isogenic pairs (like sensitive parent and resistant derivative lines) are highly valuable. Many of our high-grade serous carcinoma (HGSC) models have documented platinum sensitivity/resistance profiles to help you choose.
Do you have cell lines representing different histological subtypes of ovarian cancer?
Yes. The collection includes major subtypes, with a focus on high-grade serous carcinoma (the most common), as well as clear cell, endometrioid, and mucinous carcinomas. It's important to select a model that aligns with the histology relevant to your research question.
Are BRCA-mutant ovarian cancer cell lines available?
Absolutely. We offer cell lines with known BRCA1 or BRCA2 mutations, which are crucial for studying homologous recombination deficiency (HRD) and the response to PARP inhibitors. Their mutation status is clearly detailed in the product information.
Can these models be used for 3D spheroid or organoid co-culture studies?
Many of our ovarian cancer cell lines are well-suited for 3D culture. They can form spheroids, and some are commonly used in co-culture systems with cancer-associated fibroblasts (CAFs) or mesothelial cells to study the tumor microenvironment.
How are the cell lines shipped and what are the storage recommendations?
They are shipped frozen on dry ice. For long-term storage, we recommend keeping vials in liquid nitrogen vapor phase. Detailed thawing and subculture protocols are provided with each shipment.
Filters Clear all filters
Species
- Cat (1)
- Human (989)
- Mouse (5)
- Rat (1)
Source
- Abdomen Metastasis (2)
- Adrenal Gland (7)
- Adrenal Gland Metastasis (2)
- Ascites (23)
- Ascites Metastasis (32)
- Bile Duct (3)
- Bladder (12)
- Blood (120)
- Bone (21)
- Bone Marrow (43)
- Bone Marrow Metastasis (18)
- Bone Metastasis (6)
- Brain (31)
- Brain Metastasis (6)
- Breast (8)
- Bronchus (1)
- Cecum (3)
- Cerebrospinal Fluid (1)
- Cerebrospinal Fluid Metastasis (1)
- Cervix (32)
- Colon (83)
- Cornea (3)
- Cutaneous Metastasis (1)
- Dermis (1)
- Duodenum (1)
- Endometrium (17)
- Esophagus (44)
- Eye (12)
- Eye Socket (5)
- Fetus (1)
- Foreskin (4)
- Gallbladder (1)
- Gingiva (2)
- Globe (2)
- Groin (1)
- Hypodermis Metastasis (5)
- Intestine (84)
- kidney (1)
- Kidney (9)
- Liver (13)
- Liver Metastasis (17)
- Lung (42)
- Lung Metastasis (8)
- Lymph Node (5)
- Lymph Node Metastasis (56)
- Muscle (4)
- Muscle Metastasis (2)
- Nose (2)
- Omentum Metastasis (2)
- Oral Cavity (10)
- Ovary (13)
- Ovary Metastasis (2)
- Pancreas (10)
- Pelvic Wall Metastasis (1)
- Pelvis (1)
- Perianal Space Metastasis (1)
- Pericardial Effusion (1)
- Pericardial Effusion Metastasis (1)
- Perineus (1)
- Peripheral Blood (119)
- Peritoneal Effusion (2)
- Peritoneum (1)
- Peritoneum Metastasis (1)
- Pharynx (3)
- Pleural Effusion (54)
- Pleural Effusion Metastasis (44)
- Prostate (4)
- Rectum (13)
- Renal Pelvis (1)
- Retroperitoneal Space (2)
- Salivary Gland (2)
- Skeletal Muscle (1)
- Skin (22)
- Skin Metastasis (3)
- Small Intestine (1)
- Small Intestine Metastasis (1)
- Soft Tissue Metastasis (1)
- Stomach (4)
- Testis (9)
- Thoracic Cavity Metastasis (6)
- Thyroid Gland (15)
- Thyroid Gland Metastasis (1)
- Tongue (5)
- Umbilical Cord (1)
- Umbilical Cord Blood (1)
- Urachus (1)
- Ureter (1)
- Uterus (53)
- Uvea (2)
- Vagina (2)
- Vulva (1)
Disease
- Acute Biphenotypic Leukemia (1)
- Acute Erythroid Leukemia (4)
- Acute Megakaryoblastic Leukemia (4)
- Acute Monocytic Leukemia (9)
- Acute Myeloid Leukemia (25)
- Acute Promyelocytic Leukemia (2)
- Adrenal Gland Neuroblastoma (11)
- Adult B Acute Lymphoblastic leukemia (1)
- Adult B Acute Lymphoblastic Leukemia (6)
- Adult T Acute Lymphoblastic Leukemia (6)
- Adult T Lymphoblastic Lymphoma (2)
- Adult T-Cell Leukemia/Lymphoma (1)
- Alveolar Rhabdomyosarcoma (4)
- Alveolar Ridge Squamous Cell Carcinoma (1)
- Amelanotic Melanoma (3)
- Ampulla of Vater Adenocarcinoma (1)
- Ampulla of Vater Adenosquamous Carcinoma (3)
- Anaplastic Astrocytoma (3)
- Anaplastic Large Cell Lymphoma (7)
- Askin Tumor (1)
- Astrocytoma (5)
- B Acute Lymphoblastic Leukemia (2)
- B-Cell Non-Hodgkin Lymphoma (5)
- Bare Lymphocyte Syndrome Type 2 (1)
- Barrett Adenocarcinoma (2)
- Benign Prostatic Hyperplasia (1)
- Bladder Carcinoma (12)
- Bladder Squamous Cell Carcinoma (1)
- Breast Adenocarcinoma (1)
- Breast Carcinoma (9)
- Breast Ductal Carcinoma (2)
- Burkitt Lymphoma (17)
- Canavan Disease (1)
- Cecum Adenocarcinoma (3)
- Central Nervous System Lymphoma (2)
- Cervical Adenocarcinoma (2)
- Cervical Adenosquamous Carcinoma (2)
- Cervical Small Cell Carcinoma (1)
- Cervical Squamous Cell Carcinoma (2)
- Childhood B Acute Lymphoblastic Leukemia (13)
- Childhood T Acute Lymphoblastic Leukemia (16)
- Childhood T Lymphoblastic Lymphoma (1)
- Cholangiocarcinoma (2)
- Chronic Eosinophilic Leukemia (1)
- Chronic Lymphocytic Leukemia (2)
- Chronic Myeloid Leukemia (23)
- Clear Cell Renal Cell Carcinoma (2)
- Colon Adenocarcinoma (53)
- Colon Carcinoma (33)
- Colorectal Adenocarcinoma (1)
- Colorectal Carcinoma (1)
- Congenital Pure Red Cell Aplasia (1)
- Cutaneous Melanoma (10)
- Dedifferentiated Chondrosarcoma (1)
- Desmoplastic Melanoma (1)
- Diffuse Large B-Cell Lymphoma (28)
- Down Syndrome (2)
- EBV-Related Burkitt Lymphoma (12)
- Embryonal Carcinoma (3)
- Embryonal Rhabdomyosarcoma (3)
- Endometrial Adenocarcinoma (13)
- Endometrial Adenosquamous Carcinoma (2)
- Endometrial Carcinoma (2)
- Endometrioid Stromal Sarcoma (1)
- Epithelioid Hemangioendothelioma (1)
- Epithelioid Sarcoma (3)
- Esophageal Adenocarcinoma (6)
- Esophageal Squamous Cell Carcinoma (41)
- Essential Thrombocythemia (1)
- Ewing Sarcoma (2)
- Extraskeletal Myxoid Chondrosarcoma (1)
- Fanconi Anemia (1)
- Fibrosarcoma (1)
- Follicular Lymphoma (2)
- Gallbladder Carcinoma (2)
- Gallbladder Undifferentiated Carcinoma (2)
- Gastric Adenocarcinoma (6)
- Gastric Adenosquamous Carcinoma (1)
- Gastric Carcinoma (5)
- Gastric Choriocarcinoma (1)
- Gastric Fundus Carcinoma (1)
- Gastric Signet Ring Cell Adenocarcinoma (1)
- Gastric Small Cell Carcinoma (2)
- Gastric Tubular Adenocarcinoma (5)
- Gastroesophageal Junction Adenocarcinoma (1)
- Gestational Choriocarcinoma (1)
- Gingival Squamous Cell Carcinoma (2)
- Glioblastoma (18)
- Gliosarcoma (1)
- Hairy Cell Leukemia (1)
- Hepatoblastoma (2)
- Hepatocellular Carcinoma (6)
- Hepatosplenic T-Cell Lymphoma (2)
- Hereditary Thyroid Gland Medullary Carcinoma (1)
- High Grade B-Cell Lymphoma (1)
- High Grade Ovarian Serous Adenocarcinoma (8)
- Hodgkin Lymphoma (9)
- Hypopharyngeal Squamous Cell Carcinoma (2)
- Infectious Mononucleosis (1)
- Intrahepatic Cholangiocarcinoma (6)
- Invasive Breast Carcinoma of No Special Type (12)
- Kidney Neoplasm (1)
- Kidney Rhabdoid Tumor (1)
- Krukenberg Tumor (1)
- Liposarcoma (1)
- Lung Adenocarcinoma (17)
- Lung Giant Cell Carcinoma (8)
- Lung Large Cell Carcinoma (9)
- Lung Mucoepidermoid Carcinoma (1)
- Lung Non-Small Cell Carcinoma (2)
- Lung Small Cell Carcinoma (25)
- Lung Squamous Cell Carcinoma (9)
- Lymphoblastic Lymphoma (1)
- Malignant Peripheral Nerve Sheath Tumor (1)
- Mantle Cell Lymphoma (5)
- Mature Gastric Teratoma (1)
- Maxillary Sinus Squamous Cell Carcinoma (1)
- Medulloblastoma (3)
- Melanoma (24)
- Meningioma (2)
- Minimally Invasive Lung Adenocarcinoma (1)
- Monophasic Synovial Sarcoma (1)
- Mouse Intestinal Tract Neuroendocrine Adenoma (1)
- Mouse Mammary Gland Malignant Neoplasm (2)
- Mouse Plasmacytoma (1)
- Mycosis Fungoides (1)
- Myelodysplastic Syndrome (1)
- Myxofibrosarcoma (1)
- Natural Killer Cell Lymphoblastic Leukemia/Lymphoma (2)
- Neuroblastoma (26)
- Oral Cavity Squamous Cell Carcinoma (15)
- Osteoid Osteoma (1)
- Osteosarcoma (15)
- Ovarian Carcinoma (1)
- Ovarian Clear Cell Adenocarcinoma (1)
- Ovarian Endometrioid Adenocarcinoma (4)
- Ovarian Granulosa Cell Tumor (1)
- Ovarian Mucinous Adenocarcinoma (2)
- Ovarian Serous Adenocarcinoma (2)
- Ovarian Serous Cystadenocarcinoma (2)
- Ovarian Small Cell Carcinoma (1)
- Pancreatic Adenocarcinoma (13)
- Pancreatic Carcinoma (5)
- Pancreatic Ductal Adenocarcinoma (12)
- Papillomavirus-Independent Cervical Squamous Cell Carcinoma (1)
- Papillomavirus-Related Cervical Adenocarcinoma (7)
- Papillomavirus-Related Cervical Squamous Cell Carcinoma (4)
- Papillomavirus-Related Endocervical Adenocarcinoma (16)
- Paroxysmal Nocturnal Hemoglobinuria (3)
- Pharyngeal Squamous Cell Carcinoma (1)
- Plasma Cell Myeloma (15)
- Pleural Epithelioid Mesothelioma (5)
- Pleural Sarcomatoid Mesothelioma (2)
- Poorly Differentiated Thyroid Gland Carcinoma (1)
- Primary Cutaneous T-Cell Non-Hodgkin Lymphoma (1)
- Primary Effusion Lymphoma (7)
- Primitive Neuroectodermal Tumor (1)
- Prostate carcinoma (1)
- Prostate Carcinoma (9)
- Rectal Adenocarcinoma (13)
- Rectosigmoid Adenocarcinoma (1)
- Recurrent Bladder Carcinoma (1)
- Renal Cell Carcinoma (7)
- Renal Pelvis Urothelial Carcinoma (1)
- Retinoblastoma (11)
- Sacral Chordoma (1)
- Sacrococcygeal Teratoma (1)
- Salivary Gland Squamous Cell Carcinoma (1)
- Sezary Syndrome (1)
- Shwachman-Diamond Syndrome (1)
- Skin Squamous Cell Carcinoma (2)
- Splenic Marginal Zone Lymphoma (1)
- Testicular Embryonal Carcinoma (8)
- Testicular Teratoma (2)
- Testicular Yolk Sac Tumor (1)
- Thyroid Gland Anaplastic Carcinoma (10)
- Thyroid Gland Follicular Carcinoma (4)
- Thyroid Gland Papillary Carcinoma (3)
- Thyroid Gland Sarcoma (1)
- Thyroid Gland Squamous Cell Carcinoma (2)
- Tongue Adenosquamous Carcinoma (1)
- Tongue Squamous Cell Carcinoma (6)
- Type I Endometrial Adenocarcinoma (1)
- Ureter Urothelial Carcinoma (1)
- Uterine Carcinosarcoma (2)
- Uterine Corpus Leiomyosarcoma (1)
- Uterine Corpus Sarcoma (2)
- Uveal Melanoma (2)
- Vaginal Melanoma (2)
- Vulvar Melanoma (1)
- Vulvar Squamous Cell Carcinoma (1)
Description: Species: human female 60 years old; Tissue: ovary; Tumor: adenocarcinoma, low differentiated; G3 ...
Description: Established from the solid omental metastasis of a mucinous papillary adenocarcinoma of the ovary ...
Description: Established from the ascites fluid stemming from the colon metastasis of a 46-year-old white woman ...
Description: Established from the ascitic fluid of a 56-year-old Caucasian woman with dedifferentiated serous ...
Description: Established post-hysterectomy from the tumor tissue of a 65-year-old Japanese woman with malignant ...
Description: Human cell line derived from ovarian cancer.
Description: Japanese ovarian serous adenocarcinoma. Said CA125 producing. Cell growth is slow.
Description: Human ovary serous cyst adenocarcinoma cell line. Cell growth is slow.
Description: Human ovary mucinous adenocarcinoma cell line.
Description: established from the ovary tissue of a 64-year-old woman with high grade ovarian serous ...
Description: The Adriamycin-resistant cell line OVCAR-8/ADR has been developed by repeatedly exposing the parent ...
Description: established from ovary of a 47-year-old female with ovarian endometrioid adenocarcinoma
Description: The cells are distributed for research purposes only. The culture condition is 37℃,95% air, carbon ...
Description: Established in 1982 by T.C. Hamilton, et al. from the malignant ascites of a patient with ...
Description: The SW 626 cell line was initiated by A. Leibovitz in January 1974 at the Scott and White Clinic, ...
Description: Human ovarian granulosa tumour cell line established from a solid primary tumour.
Description: Granulosa cell tumor. Possible to produce progesterone after HCG addition. Cell growth is slow.

















